Immunai’s Post

In the latest issue of Drug Discovery World, experts all agree that AI is the next major inflection point for #DrugDiscovery, including Elsevier’s own SVP of Generative AI, Cameron Ross. 💊 He explains that AI can dramatically shorten the costly small molecule drug discovery process in the latest issue on pages 8-9: http://spkl.io/60444vkYo. #LifeSciences #Pharma #RandD

Message me to learn more about Atlas™ mice, the next generation of transgenic mice for therapeutic antibody discovery!

Check out the recent blog from Kibur Medical!

Revolutionize your antibody discovery process with MAbSilico! 🚀 In just 21 days, our AI-based solutions deliver fully characterized, high-affinity, and epitope-specific humanized antibodies. Say goodbye to lengthy lead candidate searches and hello to efficient therapeutic development! 💡 🌐 mabsilico.com #Antibody #AI #ML #DrugDesign #DrugDiscovery #BioTechs

In the latest edition of Drug Discovery World, Elsevier’s SVP of Generative AI, Cameron Ross, talks about how AI can dramatically shorten the costly small molecule drug discovery process. 💊 Read more from Cameron and other industry experts on the future of drug discovery in 2024 on pages 8-9: http://spkl.io/60434vwav #Pharma #Elsevier #Innovation #AI

Some Hot stuff in the Cold.. this morning while walking Bo Derek🦮  in the crispy -21°C air, I was reflecting on a really nice paper I read yesterday. And I can tell you, this is Hot stuff.. if your like me are interested in the new era that we are entering, the era of "#RNAissance" you really should read this paper “Breaking the mold with RNA—a “RNAissance” of life science” Jan 9, 2024 | npj Genomic Medicine As a CDMO professional, three things really stuck with me: • The urgent need for agile #manufacturing in #RNA therapeutics. • Our crucial role in scaling up these revolutionary treatments. • The potential shifts in regulatory landscapes and commercial models. The RNAissance isn't just scientific progress; it's a transformation in pharma manufacturing. Let's innovate and adapt together in this exciting era! #RNAissance #CDMO #PharmaManufacturing #Innovation NorthX Biologics

AI will revolutionize drug discovery! Our NanoNail device helps to identify predictive biomarkers and optimal drug combinations and is part of this rapidly-advancing area of drug discovery. Read more about AI in drug discovery in this McKinsey article: https://lnkd.in/ethFnxeq #artificialintelligence #ai #drugdevelopment #mckinseyinsights #kiburmed

🩺 Precision Oncology is undergoing a transformative shift, leveraging artificial intelligence (#AI), machine learning (#ML), robotics, and big data-driven tools to redefine targeted treatments. 🩺 Genetic insights are equipping #oncologists with personalized diagnostics, revolutionizing #patientcare. 🩺 For #cardiometabolic diseases, the landscape is shifting towards patient-centric approaches, blending therapies and #geneticresearch for precision health. 🩺 As the #pharmaceutical industry adapts to environmental regulations, #sustainability is driving innovation and strategic partnerships for a greener future. Which #growthopportunities are contributing to the integration and adoption of #PrecisionOncology, Precision Cardiometabolic Solutions, and Sustainability in Pharma? --> Know More: https://frost.ly/9o9 Robin Joffe | Reenita Das | Unmesh Lal | Mark Dagher | Tamer Abu Elhassan | Nimisha Iyer #precisionmedicine #precisionhealth

Check out the latest from Drug Discovery World, including insights into the effects of AI on drug development from industry experts, including Elsevier's own Cameron Ross. See pages 8-9 for industry trends and predictions for the upcoming year!